AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 73 filers reported holding AUTOLUS THERAPEUTICS PLC in Q4 2021. The put-call ratio across all filers is 0.49 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,580 | +3.7% | 18,275 | +5.9% | 0.00% | – |
| Q2 2023 | $41,055 | +31.8% | 17,250 | +1.9% | 0.00% | – |
| Q1 2023 | $31,142 | -3.2% | 16,925 | 0.0% | 0.00% | – |
| Q4 2022 | $32,158 | +3115.8% | 16,925 | +3285.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 500 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | – | 500 | +900.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 50 | -50.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | -97.1% | 100 | -98.3% | 0.00% | – |
| Q1 2021 | $34,000 | -26.1% | 5,850 | +14.7% | 0.00% | – |
| Q4 2020 | $46,000 | -20.7% | 5,100 | +2.0% | 0.00% | – |
| Q3 2020 | $58,000 | -51.7% | 5,000 | -33.3% | 0.00% | – |
| Q2 2020 | $120,000 | +160.9% | 7,500 | -8.5% | 0.00% | – |
| Q1 2020 | $46,000 | – | 8,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,283,966 | $15,166,000 | 1.40% |
| Sio Capital Management, LLC | 591,870 | $3,930,000 | 0.98% |
| TFG Asset Management GP Ltd | 2,500,000 | $16,600,000 | 0.90% |
| Ikarian Capital, LLC | 1,356,048 | $9,004,000 | 0.73% |
| SABBY MANAGEMENT, LLC | 400,050 | $2,656,000 | 0.37% |
| Nantahala Capital Management | 1,793,500 | $11,909,000 | 0.34% |
| Regency Capital Management Inc.\DE | 57,000 | $378,000 | 0.29% |
| Eversept Partners, LP | 473,074 | $3,141,211 | 0.21% |
| MYDA Advisors LLC | 85,000 | $564,000 | 0.14% |
| Henry James International Management Inc. | 54,047 | $359,000 | 0.10% |